ASTRAZENECA PHARMA INDIA
Back to Cashflow Statement
|
ASTRAZENECA PHARMA INDIA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-66 Cr | ₹-44 Cr | ₹-24 Cr | ₹-9.46 Cr | ₹-8.97 Cr |
What is the latest Cash Flow from Financing Activities ratio of ASTRAZENECA PHARMA INDIA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-66 Cr |
| Mar2024 | ₹-44 Cr |
| Mar2023 | ₹-24 Cr |
| Mar2022 | ₹-9.46 Cr |
| Mar2021 | ₹-8.97 Cr |
How is Cash Flow from Financing Activities of ASTRAZENECA PHARMA INDIA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-66 Cr | Negative | |
| Mar2024 | ₹-44 Cr | Negative | |
| Mar2023 | ₹-24 Cr | Negative | |
| Mar2022 | ₹-9.46 Cr | Negative | |
| Mar2021 | ₹-8.97 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹22,460.1 Cr | 4.3% | 5.7% | 10.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,610.0 Cr | -2.1% | 13.6% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,279.0 Cr | -2% | 6.2% | 3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,649.0 Cr | 0.5% | 8.2% | 39% | Stock Analytics | |
| CIPLA | ₹114,469.0 Cr | 1.3% | 9.5% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,955.0 Cr | 0.6% | 1% | 8.8% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | 4.3% |
5.7% |
10.7% |
| SENSEX | 1.1% |
-2.1% |
-6.4% |
You may also like the below Video Courses